Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS).
Bielack SS, Mettmann V, Hecker-Nolting S, Borkhardt A, Hardes J, Kager L, von Kalle T, Kevric M, Koscielniak E, Kratz CP, Kühne T, Nathrath M, Rossig C, Sorg B, Sparber-Sauer M, Werner M, Blattmann C. Bielack SS, et al. Among authors: kager l. Pediatr Blood Cancer. 2024 Dec;71(12):e31344. doi: 10.1002/pbc.31344. Epub 2024 Sep 29. Pediatr Blood Cancer. 2024. PMID: 39344062
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS; Cooperative German-Austrian-Swiss Osteosarcoma Study Group. Kager L, et al. J Clin Oncol. 2003 May 15;21(10):2011-8. doi: 10.1200/JCO.2003.08.132. J Clin Oncol. 2003. PMID: 12743156
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Andreou D, Bielack SS, Carrle D, Kevric M, Kotz R, Winkelmann W, Jundt G, Werner M, Fehlberg S, Kager L, Kühne T, Lang S, Dominkus M, Exner GU, Hardes J, Hillmann A, Ewerbeck V, Heise U, Reichardt P, Tunn PU. Andreou D, et al. Among authors: kager l. Ann Oncol. 2011 May;22(5):1228-1235. doi: 10.1093/annonc/mdq589. Epub 2010 Oct 28. Ann Oncol. 2011. PMID: 21030381 Free article.
Controversies in childhood osteosarcoma.
Bielack S, Kempf-Bielack B, Von Kalle T, Schwarz R, Wirth T, Kager L, Whelan J. Bielack S, et al. Among authors: kager l. Minerva Pediatr. 2013 Apr;65(2):125-48. Minerva Pediatr. 2013. PMID: 23612259
Osteosarcoma of the mobile spine.
Zils K, Bielack S, Wilhelm M, Werner M, Schwarz R, Windhager R, Hofmann-Wackersreuther G, Andus T, Kager L, Kuehne T, Reichardt P, von Kalle T. Zils K, et al. Among authors: kager l. Ann Oncol. 2013 Aug;24(8):2190-5. doi: 10.1093/annonc/mdt154. Epub 2013 Apr 23. Ann Oncol. 2013. PMID: 23613478 Free article.
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.
Collins M, Wilhelm M, Conyers R, Herschtal A, Whelan J, Bielack S, Kager L, Kühne T, Sydes M, Gelderblom H, Ferrari S, Picci P, Smeland S, Eriksson M, Petrilli AS, Bleyer A, Thomas DM. Collins M, et al. Among authors: kager l. J Clin Oncol. 2013 Jun 20;31(18):2303-12. doi: 10.1200/JCO.2012.43.8598. Epub 2013 May 13. J Clin Oncol. 2013. PMID: 23669227
240 results